Model
Edge
Halozyme Therapeutics, Inc.
0001662521
Filing Type
4
Filing Date
5/6/2026
Updated
5/7/26, 5:01 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership